Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Ball

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Archives of Internal Medicine|February 1, 1989
Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarctionJ M Gore, J M Corrao, R J Goldberg, et al.
Journal of the American College of Cardiology|February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 StudyR C Becker, J S Hochman, C P Cannon, et al.
Cardiology|January 1, 1991
Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast mediaR C Becker, C Clyne, B H Weiner, et al.
British Journal of Anaesthesia|January 1, 1993
Genetic linkage analysis of chromosome 19 markers in malignant hyperthermiaS P Ball, H R Dorkins, F R Ellis, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionM I Furman, L A Krueger, M D Linden, et al.
American Heart Journal|May 20, 1998
Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) ParticipantsR C Becker, M Burns, J M Gore, et al.
American Heart Journal|January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium InvestigatorsR C Becker, S P Ball, P Eisenberg, et al.
Annals of Clinical Research|January 1, 1986
Molecular analysis of X-linked diseasesK E Davies, S P Ball, H R Dorkins, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Molecular analysis of human X-linked diseasesK E Davies, S P Ball, H R Dorkins, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Archives of Internal Medicine|February 1, 1989
Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarctionJ M Gore, J M Corrao, R J Goldberg, et al.
Journal of the American College of Cardiology|February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 StudyR C Becker, J S Hochman, C P Cannon, et al.
Cardiology|January 1, 1991
Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast mediaR C Becker, C Clyne, B H Weiner, et al.
British Journal of Anaesthesia|January 1, 1993
Genetic linkage analysis of chromosome 19 markers in malignant hyperthermiaS P Ball, H R Dorkins, F R Ellis, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionM I Furman, L A Krueger, M D Linden, et al.
American Heart Journal|May 20, 1998
Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) ParticipantsR C Becker, M Burns, J M Gore, et al.
American Heart Journal|January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium InvestigatorsR C Becker, S P Ball, P Eisenberg, et al.
Annals of Clinical Research|January 1, 1986
Molecular analysis of X-linked diseasesK E Davies, S P Ball, H R Dorkins, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Molecular analysis of human X-linked diseasesK E Davies, S P Ball, H R Dorkins, et al.
Pageof 3